Clinical Trial

A Study of SHR-1918 In Participants With Hypertriglyceridemia

Name: A Study of SHR-1918 In Participants With Hypertriglyceridemia — clinical trial record (NCT07349615)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

The purpose of the study is to evaluate the efficacy and safety of SHR-1918 in patients with hypertriglyceridemia. The efficacy and safety of SHR-1918 will be evaluated after 24-weeks and 48-weeks treatment.

Protocol Amendment History 1 change

critical Recruitment opened 2026-06-17

Trial Details

NCT Number	NCT07349615
Lead Sponsor	Beijing Suncadia Pharmaceuticals Co., Ltd
Conditions	Hypertriglyceridemia
Enrollment	360 participants
Start Date	2026-04-01
Primary Completion	2027-11 (estimated)
Study Completion	2027-11 (estimated)
Updated on ClinicalTrials.gov	2026-06-16